Skip to main content
. 2014 Nov 17;5:577. doi: 10.3389/fimmu.2014.00577

Table 3.

Results of genome-wide association (stage 1) and replication (stage 2a) analyses of GPA association.

Combined analysis (n = 750 case patients, n = 1820 controls)
Gene Chromosome SNP Nucleotide change OR P-value
HLA-DPB1 6 rs9277554 T > C 0.24 1.92 × 10−50
HLA-DPA1 6 rs9277341 C > T 0.33 2.18 × 10−39
Non-HLA region
WSCD1 17 rs7503953 A > C 1.50 1.93 × 10−7
COBL 7 rs1949829 T > C 1.78 4.19 × 10−7
CCDC86 11 rs595018 A > G 1.46 1.60 × 10−7
DCTD 4 rs4862110 C > T 1.44 2.14 × 10−6

Combined analysis (n = 987 case patients, n = 2731 controls)

SEMA6A 5 rs26595 C > T 0.74 2.09 × 10−8

c-ANCA-positive patients vs. controls (patients, n = 578; controls, n = 1,820)
Gene Chromosome SNP Nucleotide change OR P-value

VCRC GWAS: associations of MHC Loci with c-ANCA-positive GPA
HLA-DPB1 6 rs9277554 T > C 0.16 4.7 × 10−57
HLA-DPA1 6 rs9277341 C > T 0.27 2.30 × 10−42

GPA, granulomatosis with poliangiitis; SNP, single-nucleotide polymorphism; OR, odds-ratio; VCRC, Vasculitis Clinical Research Consortium; ANCA, autoantibodies to neutrophils.